EPO administration does not decrease <i>Hamp</i> expression in <i>mask</i> mice. by Jana Frýdlová (163557)

Cytokine dependent decrease in vSMC viability after type I NKT cell activation. by Gijs H. M. van Puijvelde (500345)

Decrease of NF-κB activity in tumor tissue of CCR5^−/− mice. by Ju Kyoung Song (324058)

“…<b>C</b>, Immunolfluorescence analysis of p50 confirmed that the intensities of nuclear staining for p50 were decreased in the tumor tissues of CCR5^−/− mice. …”

Inhibitor assay of ACER3. by Jae Kyo Yi (13570063)

Subjects:

HAART does not affect CTLA-4 expression, but significantly decreases CD39 expression in Tregs. by Pietro Presicce (144163)

HAART decreased enhanced expression of cell cycling markers in Tregs from HIV-infected subjects. by Pietro Presicce (144163)

Decrease of excitability in small IB4-positive TG neurons over-expressing TRESK channels. by Zhaohua Guo (383295)

Adiponectin-induced Irak3 plays an important role in rosiglitazone-mediated decrease of Mcp1. by Maarten Hulsmans (181118)

Decreasing Fertility Rate Correlates with the Chronological Increase and Geographical Variation in Incidence of Kawasaki Disease in Japan by Yoshiro Nagao (50850)

Chronic high glucose induces apoptosis and proteasome activities decrease in INS-1E cells. by Christophe Broca (538652)

<i>Pw1</i> deletion does not result in significant decrease in oxytocin production and release. by Anne-Lyse Denizot (3170142)

Decreased survival, splenomegaly, thrombocytopenia and megakaryocyte alterations in SCID-Rasa3^−/− mice. by Patricia Molina-Ortiz (167505)

Definitions of the features selected [50]. by Yu Zhang (12946)

Discrimination of rippled-spectrum patterns in noise: A manifestation of compressive nonlinearity - Fig 6 by Olga N. Milekhina (812701)

Decrease in the hemolymph sugar level of hyperglycemic silkworms and increase in AMPK phosphorylation in the fat body by AICAR. by Yasuhiko Matsumoto (206628)

AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

“…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”

SHIP-1 decreases NOD2-induced NF-κB activation in epithelial cells. by Claude Condé (150801)

FGF8b decreased GnRH mRNA in GT1-7 cells. by Natasha N. Mott (341221)

Silencing of Doublecortin-Like (DCL) Results in Decreased Mitochondrial Activity and Delayed Neuroblastoma Tumor Growth by Carla S. Verissimo (463419)

FG-2216 decreased plasma markers of cardiac injury in Nx-Ob-ZSF1 rats. by Pierre E. Signore (11218497)